SUB-Q QuickSeal Closes Hole In Boston Scientific Endovascular Line
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will enter the rapidly expanding vascular access closure device market in May through the distribution of SUB-Q's QuickSeal vascular sealing device, under a licensing and equity agreement announced April 23. The QuickSeal earned PMA approval on March 25
You may also be interested in...
SUB-Q sub-estimate
QuickSeal vascular sealing device maker earns FDA approval based on a 398-patient trial, not 39 patients, as previously reported ("1The Gray Sheet" April 29, 2002, p. 19)...
SUB-Q sub-estimate
QuickSeal vascular sealing device maker earns FDA approval based on a 398-patient trial, not 39 patients, as previously reported ("1The Gray Sheet" April 29, 2002, p. 19)...
Boston Scientific seeks closure
Company becomes exclusive worldwide distributor of Therus' vascular closure products and will make an equity investment with a future option to buy the Seattle company under a May 2 agreement. A feasibility study of Therus' HIFU (high intensity focused ultrasound) technology to close femoral puncture wounds was recently completed, and the firm expects to have a product in Europe in 2003 and in the U.S. by 2004. On April 23, Boston Scientific announced a licensing and equity agreement with SUB-Q for its QuickSeal vascular sealing device (1"The Gray Sheet" April 29, 2002, p. 19). Separately, Boston Scientific announces April 30 that it will take over distribution rights for Onux Medical's Touche tissue fixation suturing products and will help Onux develop technology to treat peptic ulcer disease...